At $1.55 billion, the University of Michigan is the #1 public university in research spending in the United States, and the Medical School is responsible for nearly half of those research expenditures. We are a significant research and economic engine in the region, and this year U.S. News & World Report ranked our hospitals #5 in the nation.
With 10,000+ faculty, students, and staff studying almost 3,000 scientific projects, it's impossible to tell you about all the breakthroughs taking place every day at the University of Michigan Medical School. We invite you to take a closer look at the following metrics and stories which offer a brief sampling of a year in research among the "leaders and best," developing new treatments and technologies that are on a path to positively impacting patients and their families.
"From basic to translational research, and on to the clinic, policy and commercialization, U-M Medical School researchers are firing on all cylinders across the research spectrum as we further scientific inquiry and ultimately work to improve human health."
"Discovery and translational research continue to be absolutely critical to our mission to advance healthcare in Michigan and around the world, and is and always will be of highest priority for Michigan Medicine."
Nearly 1 in 8 couples in the U.S. face infertility, and about half of those cases can be attributed to sperm abnormalities in the male partner. As the root causes often remain a mystery, Sue Hammoud, Ph.D., is researching how the basic biology behind sperm development could one day lead to renewed hope for people wanting to grow their families.
Harnessing the power of the body's immune system holds incredible promise for combating a range of conditions, and has transformed the way researchers are approaching cancer treatment. Weiping Zou, M.D., Ph.D., is leading a multidisciplinary laboratory that is investigating immunotherapy drugs and the human cancer microenvironment.
In today's health care environment, patients and their families are being encouraged to take an active role in decision-making about prevention and treatment. For many caregivers, engagement can mean additional challenges and stress. Helen Kales, M.D., is researching both mental health issues in older patients, as well as looking at innovative support options for their caregivers.
According to the Centers for Disease Control and Prevention, 115 Americans die every day from an opioid overdose, many of them resulting from the abuse of prescribed medications. Michael Englesbe, M.D., along with Ryan Howard, M.D., and Jay Lee, M.D., are helping to address this dangerous epidemic through their research into safer prescribing practices.
Lipodystrophy is a rare, currently incurable syndrome tied to a number of diseases, and can lead to diabetes and very high triglyceride levels. Life-threatening complications are caused by a decrease in the hormone Leptin, and result in symptoms like uncontrolled body fat loss or accumulation, and a stressed liver. Elif A. Oral, M.D., M.S., currently has the largest lipodystrophy patient population in the United States, and spearheaded the development of the only approved therapy for the condition.
Richard and Susan Rogel are on a mission to boost innovative cancer research and develop the next generation of cancer pioneers. In 2018 they committed $150 million to the University of Michigan Comprehensive Cancer Center to realize that vision.
Are you ready to join a community of people who are passionate about finding cures, preventing disease, and improving the quality of life for patients and their families?
From proposal development to grant and regulatory reviews to core labs, throughout the year our research enterprise is supported by the many units of the Medical School Office of Research.